fbpx
Menu

Novelion Therapeutics Reports Third Quarter 2018

Share

Novelions Chief Financial Officer Michael Price commented, In the third quarter we saw a positive impact from the cost reduction initiatives that we …

[Read on via official release]

Source: US SEC
View full document: EX-1_of_8-K_for_NOVELION_THERAPEUTICS_INC__8-K-11-09-2018